PARISI, SAVERIO
 Distribuzione geografica
Continente #
NA - Nord America 7.897
EU - Europa 992
AS - Asia 725
SA - Sud America 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 9.626
Nazione #
US - Stati Uniti d'America 7.881
IT - Italia 347
CN - Cina 345
SG - Singapore 297
FI - Finlandia 141
DE - Germania 120
SE - Svezia 100
UA - Ucraina 100
FR - Francia 96
GB - Regno Unito 62
VN - Vietnam 49
HK - Hong Kong 15
CA - Canada 11
IN - India 11
IE - Irlanda 10
ES - Italia 5
MX - Messico 5
BE - Belgio 4
NL - Olanda 4
AU - Australia 3
BR - Brasile 3
KH - Cambogia 3
EU - Europa 2
RU - Federazione Russa 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
EC - Ecuador 1
EG - Egitto 1
GR - Grecia 1
IQ - Iraq 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 9.626
Città #
Fairfield 1.307
Woodbridge 837
Chandler 696
Houston 587
Ashburn 527
Ann Arbor 433
Seattle 429
Cambridge 421
Wilmington 419
Jacksonville 408
Singapore 229
Boardman 215
Princeton 194
San Diego 166
Santa Clara 112
Padova 110
Roxbury 97
Medford 81
Helsinki 58
Beijing 52
Dong Ket 48
Nanjing 47
Des Moines 46
Guangzhou 34
New York 25
Nanchang 23
London 18
Rome 18
Shenyang 16
Hebei 15
Aprilia 14
Hong Kong 13
Norwalk 13
Ogden 13
Jiaxing 12
Los Angeles 12
Falls Church 11
Dublin 10
Redwood City 10
Frankfurt am Main 9
Hefei 9
Burolo 8
Jinan 8
Kunming 8
Milan 8
Kharkiv 7
Paris 7
Tianjin 7
Changsha 6
Medicina 6
Ningbo 6
Santa Cruz 6
Shanghai 6
Borås 5
Kilburn 5
Lappeenranta 5
Orange 5
Ottawa 5
Washington 5
Auburn Hills 4
Bergamo 4
Dallas 4
Chicago 3
Dearborn 3
Florence 3
Frederick 3
Lenna 3
Perth 3
Pietro 3
Redmond 3
Taiyuan 3
Zhengzhou 3
Afragola 2
Altavilla 2
Ankara 2
Arce 2
Brussels 2
Buffalo 2
Campobasso 2
Camponogara 2
Chiampo 2
Columbus 2
Due Carrare 2
Genoa 2
Ghent 2
Gunzenhausen 2
Haikou 2
Indiana 2
Lanzhou 2
Naples 2
Novosibirsk 2
Phoenix 2
Pianiga 2
Porto Garibaldi 2
Prescot 2
Pune 2
Richland 2
Rivoli 2
Rovigo 2
San Martino Buon Albergo 2
Totale 8.005
Nome #
Viral infections of the central nervous system in elderly patients: A retrospective study 176
Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy. 167
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' 165
Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection 161
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 152
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications 152
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 146
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014 141
Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection 134
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 133
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 132
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 129
Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data. 126
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 124
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 124
Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities 123
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection. 121
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 120
Virological testing of cerebrospinal fluid in children aged less than 14 years with a suspected central nervous system infection: A retrospective study on 304 consecutive children from January 2012 to May 2015 117
Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a Patient: First Case in Europe 112
Detection of an early HIV-1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period 110
Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities. 109
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 109
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: A 24-month longitudinal study 109
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV. 108
Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection 105
Deep neck abscesses due to Acinetobacter baumanii infection. 101
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients 100
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 99
Human immunodeficiency virus polymorphisms and zidovudine resistance 99
Legal scenarios in the coronavirus time: Medico legal implications in the aspects of governance 99
Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy. 97
Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers. 97
Distribution of the CCR5 Delta 32 allele in Italian HIV type 1-infected and normal individuals 96
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 96
Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients. 95
Prevalence, molecular epidemiology and intra-hospital acquisition of Klebsiella pneumoniae strains producing carbapenemases in an Italian teaching hospital from January 2015 to September 2016. 95
Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004–2012 in the Veneto Region, Italy 94
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 93
Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients 93
Drug-resistance mutations can be archived very early in HIV primary infection 91
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 90
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy 89
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 89
Rational Diagnostic and therapeutic management of deep neck infections. Analysis of 233 consecutive cases 88
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 87
null 87
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 86
Long-term therapy with nevirapine and tropism 86
Unboosted fosamprenavir is associated with low drug exposure in hiv-infected patients with mild-moderate liver impairment for hcv-related cirrhosis. 85
Molecular epidemiology of Enterococcus faecium isolates from an Italian hospital 85
HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection 85
Association between cellular human immunodeficiency virus DNA level andimmunological parameters in patients with undetectable plasma viremia levelduring highly active antiretroviral therapy. 83
Primary human herpesvirus 8 infection in immunocompetent children 82
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS 82
Infections in liver and lung transplant recipients: A national prospective cohort 82
Human immunodeficiency virus infection of human bone marrow stromal myoid cells 82
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 81
Switching of Inferred Tropism Caused by HIV during Interruption of Antiretroviral Therapy 80
Detection of hepatitis C virus in an exhumed body identified the origin of a nosocomial transmission that caused multiple fatal diseases 80
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients 79
Biological phenotype, replicative capacity and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 78
Sustained Virological Response and Baseline Predictors in HIV-HCV Coinfected Patients Retreated with Pegylated Interferon and Ribavirin after Failing a Previous Interferon-Based Therapy: Systematic Review and Meta-Analysis 76
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects 76
Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. 74
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy 74
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 73
Anti-HIV gene therapy strategies combining multiple siRNA with the entry inhibitor 73
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 73
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 70
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load during different antiretroviral regimens. 69
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 69
HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective. 68
Virological efficacy of abacavir: systematic review and meta-analysis 68
EFFICIENT AND REPRODUCIBLE NEW SEMIMICROMETHOD FOR THE DETECTION AND TITRATION OF HIV IN HUMAN PLASMA 64
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study 63
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells 62
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors 62
Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019 61
Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ (Nature, (2020), 584, 7821, (425-429), 10.1038/s41586-020-2488-1) 58
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals 57
Rome consensus conference - statement; human papilloma virus diseases in males 57
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 56
Le attività di sorveglianza di laboratorio delle infezioni batteriche invasive nella Regione Veneto (anno 2007) 55
[Oculocutaneous albinism and tyrosinuria. Description of a clinical case]. 55
Cellular proviral HIV-DNA decline and viral isolation in naive subjects with < 5000 copies/ml of HIV-RNA and > 500 x 10(6)/I CD4 cells treated with highly active antiretroviral therapy 54
Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals 53
Evaluation of the Uro4 HB&L™ system for the rapid diagnosis of lower respiratory tract infections in intensive care units 52
HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection 52
Transmission of human herpesvirus 8 by blood transfusion 50
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. 49
HIV-1 reverse transcriptase M184V and R212 K combined mutations conconfer phenotypic resistance to stavudine 46
Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia 46
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 46
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment. 45
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. 41
Viral molecular testing of cerebrospinal fluid in adults with suspected central nervous system infection in an italian university hospital laboratory: A retrospective study on 1462 consecutive patients 40
Hbcab positivity is a risk factor for an increased detectability of hiv rna after switching to a two-drug regimen lamivudine-based (2dr-3tc-based) treatment: Analysis of a multicenter italian cohort 40
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 40
Switching of HIV inferred tropism during interruption of antiretroviral therapy 37
Totale 8.820
Categoria #
all - tutte 42.060
article - articoli 41.527
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 157
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.350 0 0 0 0 195 151 194 224 248 160 94 84
2020/20211.489 85 122 72 142 89 110 72 170 215 95 192 125
2021/20221.751 45 163 165 88 63 71 82 154 208 76 234 402
2022/20231.293 312 141 66 126 206 129 7 86 140 11 58 11
2023/2024711 25 91 94 74 47 69 62 40 24 33 67 85
2024/2025791 18 192 125 92 364 0 0 0 0 0 0 0
Totale 9.791